Sumitomo Dainippon Pharma Co. Ltd., of Osaka, said it agreed to invest up to $25 million in Remiges Biopharma Fund II, a venture fund created by Remiges Ventures Inc., marking Sumitomo's second investment in a fund created by Remiges. Additional terms were not disclosed.